Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial

Chéret, Antoine, Dr ; Nembot, Georges, MD ; Mélard, Adeline, MSc ; Lascoux, Caroline, MD ; Slama, Laurence, MD ; Miailhes, Patrick, MD ; Yeni, Patrick, Prof ; Abel, Sylvie, MD ; Avettand-Fenoel, Véronique, PharmD ; Venet, Alain, MD ; Chaix, Marie-Laure, MD ; Molina, Jean-Michel, Prof ; Katlama, Christine, Prof ; Goujard, Cécile, Prof ; Tamalet, Catherine, MD ; Raffi, François, Prof ; Lafeuillade, Alain, MD ; Reynes, Jacques, Prof ; Ravaux, Isabelle, MD ; Hoën, Bruno, Prof ; Delfraissy, Jean-François, Prof ; Meyer, Laurence, Prof ; Rouzioux, Christine, Prof

The Lancet infectious diseases, 2015-04, Vol.15 (4), p.387-396 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível